04-17-2015, 08:13 AM
Interesting idea Gator, thanks. A CUPID trial for a heart drug 
With $84M in the bank they can stay afloat for about 3 years, although they don't have too much in the near-term pipeline except MYDICAR, so it's indeed a bit make or break with the phase 2b test.

With $84M in the bank they can stay afloat for about 3 years, although they don't have too much in the near-term pipeline except MYDICAR, so it's indeed a bit make or break with the phase 2b test.

